advertisement

WGC-2021

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (61)

Showing records 1 to 25

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Franca JR
International Journal of Pharmaceutics 2019; 570: 118662
82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Ha JY
Chonnam medical journal 2019; 55: 156-162
82174 The Impact of R-801 Nanoparticles as a Long Acting Topical Glaucoma Therapy
Ibrahim MM
Journal of biomedical nanotechnology 2019; 15: 1968-1981
82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Yadav M
Data in brief 2019; 25: 104361
82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Juliana FR
Molecules 2019; 24:
82239 Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment
Mittal N
International Journal of Biological Macromolecules 2019; 139: 1252-1262
82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 781-792
82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Lee SM
Indian Journal of Ophthalmology 2019; 67: 1297-1302
82710 Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review
Cegielska O
Polymers 2019; 11:
82430 Latanoprost uptake and release from commercial contact lenses
Horne RR
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19
82599 Applications of microneedles in delivering drugs for various ocular diseases
Gupta P
Life Sciences 2019; 237: 116907
82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Taskar PS
Translational vision science & technology 2019; 8: 15
82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Duru Z
Cutaneous and Ocular Toxicology 2020; 39: 21-24
82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Murugesan V
British Journal of Ophthalmology 2019; 0:
82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Kumar S
Romanian journal of ophthalmology 2019; 63: 249-256
82599 Applications of microneedles in delivering drugs for various ocular diseases
Yadav KS
Life Sciences 2019; 237: 116907
82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Kesse S
Molecules 2019; 24:
82710 Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review
Sajkiewicz P
Polymers 2019; 11:
82599 Applications of microneedles in delivering drugs for various ocular diseases
Yadav KS
Life Sciences 2019; 237: 116907
82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Foureaux G
International Journal of Pharmaceutics 2019; 570: 118662
82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Sung MS
Chonnam medical journal 2019; 55: 156-162
82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Dwivedi R
British Journal of Ophthalmology 2019; 0:
82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Singh T
Romanian journal of ophthalmology 2019; 63: 249-256
82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Ozsaygili C
Cutaneous and Ocular Toxicology 2020; 39: 21-24
82239 Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment
Kaur G
International Journal of Biological Macromolecules 2019; 139: 1252-1262

Issue 20-4

Select Issue


advertisement

WGW-2021